Mandate

Vinge advises Industrifonden

May 29, 2013

Vinge has advised Industrifonden in connection with Flexenclosure’s capital raising. The company has secured an investment of SEK 160 million, half of which has been provided by IFC (International Finance Corporation) and the other by the former owners, Industrifonden and AP 2. The new capital will be used to accelerate sales and further develop Flexenclosure’s “green” telecom and IT solutions, primarily eSite and eCentre.

Flexenclosure has an aggressive research and development programme and is expanding its sales operations in emerging markets. During the last year, the company has opened offices in Nigeria, Kenya, Pakistan, India, Malaysia and Dubai. 

Vinge partner Johan Larsson advised Industrifonden.

Related

Vinge advises Aspo on its acquisition of Swed Handling

Vinge advises Aspo, listed on Nasdaq Helsinki, in the transaction whereby Aspo's subsidiary Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As part of the transaction, Aspo’s subsidiary Leipurin expands its food industry business in Sweden, via the technical food ingredient distributor Kebelco, which is a subsidiary of Swed Handling. The closing of the transaction is subject to customary regulatory approvals.
April 30, 2024

Vinge advises on the sale of Vinnergi Holding AB

Vinge has advised Sobro and other shareholders in connection with the sale of Vinnergi Holding AB to Polaris, a Nordic investment firm. In connection with the transaction, the management and employees are reinvesting a significant portion to further develop the company. The Vinnergi Group conducts operations in technology consulting and software development in Sweden, with a particular focus on telecoms, energy and real estate.
April 30, 2024

Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical

Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of up to approximately SEK 120 million in Episurf Medical.
April 24, 2024